Clinical Trials Browser

Phase 2 × Urogenital Neoplasms × Surveys and Questionnaires × Clear all

NCT02060370 2020-02-27

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Phase 2 Completed

60 enrolled 13 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms